N. Rizzo-Padoin

发表

18F-FDG labelling of hematopoietic stem cells: Dynamic study of bone marrow homing by PET-CT imaging and impact on cell functionality.

P. Merlet, L. Vercellino, L. Faivre, 2016, Current research in translational medicine.

[Contribution of radioimmunotherapy to the treatment of lymphoma].

N. Rizzo-Padoin, 2008, Annales pharmaceutiques francaises.

Changes in dipole membrane potential at the mouse blood–brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2

N. Rizzo-Padoin, A. Schinkel, S. Cisternino, 2009, Journal of neurochemistry.

Gefitinib-phenytoin interaction is not correlated with the C-erythromycin breath test in healthy male volunteers.

N. Rizzo-Padoin, C. Verstuyft, L. Becquemont, 2009, British journal of clinical pharmacology.

Geﬁtinib–phenytoin interaction is not correlated with the 14 C-erythromycin breath test in healthy male volunteers

N. Rizzo-Padoin, C. Verstuyft, L. Becquemont, 2009 .

The cytochrome P-450 2C9/2C19 but not the ABCB1 genetic polymorphism may be associated with the liver cytochrome 3A4 induction by phenytoin.

N. Rizzo-Padoin, C. Verstuyft, L. Becquemont, 2012, Journal of clinical psychopharmacology.

Amoxicillin/clavulanic acid-warfarin drug interaction: a randomized controlled trial.

N. Rizzo-Padoin, J. Alvarez, C. Verstuyft, 2011, British journal of clinical pharmacology.

Evaluation of planar bioluminescence imaging and microPET/CT for therapy monitoring in a mouse model of pigmented metastatic melanoma.

B. Hosten, L. Sarda-Mantel, N. Rizzo-Padoin, 2018, American journal of nuclear medicine and molecular imaging.

Astroglial Connexin 43 Deficiency Protects against LPS-Induced Neuroinflammation: A TSPO Brain µPET Study with [18F]FEPPA

M. Cohen-Salmon, B. Hosten, L. Sarda-Mantel, 2020, Cells.

The [14C‐N‐methyl]‐erythromycin breath test dosimetry complies with the French regulations for radiation safety

N. Rizzo-Padoin, V. Nataf, O. Bailliart, 2003, Fundamental & clinical pharmacology.

Ibogaine labeling with 99mTc-tricarbonyl: synthesis and transport at the mouse blood-brain barrier.

N. Rizzo-Padoin, X. Declèves, S. Cisternino, 2009, Journal of pharmaceutical sciences.

[18F]FEPPA a TSPO Radioligand: Optimized Radiosynthesis and Evaluation as a PET Radiotracer for Brain Inflammation in a Peripheral LPS-Injected Mouse Model

B. Hosten, L. Sarda-Mantel, N. Rizzo-Padoin, 2018, Molecules.

A comparison of radiopharmaceutical agents used for the diagnosis of pulmonary embolism

N. Rizzo-Padoin, O. Mundler, N. RIZZO-PADOIN, 2001, Nuclear medicine communications.

[Evaluation of the performance of transfer devices in a closed system using a radioactive solution of [(99m)Tc]].

N. Rizzo-Padoin, H. Broto, O. Aupée, 2011, Annales pharmaceutiques francaises.

From positron emission tomography to cell analysis of the 18-kDa Translocator Protein in mild traumatic brain injury

B. Hosten, N. Rizzo-Padoin, V. Besson, 2021, Scientific Reports.

Effect of widely used combinations of antiretroviral therapy on liver CYP3A4 activity in HIV-infected patients.

N. Rizzo-Padoin, C. Verstuyft, S. Mouly, 2006, British journal of clinical pharmacology.

[18F]MEL050 as a melanin-targeted PET tracer: Fully automated radiosynthesis and comparison to 18F-FDG for the detection of pigmented melanoma in mice primary subcutaneous tumors and pulmonary metastases.

P. Merlet, M. Chaussard, B. Hosten, 2016, Nuclear medicine and biology.

[Extravasation of radiopharmaceuticals: preventive measures and management recommended by SoFRa (Société Française de Radiopharmacie)].

L. Vercellino, B. Hosten, N. Rizzo-Padoin, 2013, Annales pharmaceutiques francaises.